Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 May;3(3):351–354. doi: 10.1128/cdli.3.3.351-354.1996

A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.

K Oishi 1, H Tanaka 1, F Sonoda 1, S Borann 1, K Ahmed 1, Y Utsunomiya 1, K Watanabe 1, T Nagatake 1, M Vaneechoutte 1, G Verschraegen 1, K Matsumoto 1
PMCID: PMC170345  PMID: 8705682

Abstract

A hybrid cell line producing a monoclonal antibody (MAb) against Moraxella (Branhamella) catarrhalis lipopolysaccharide (LPS) was established. The specificity of the MAb 1B12 to purified rough LPSs from six strains of M. catarrhalis was ascertained by enzyme-linked immunosorbent assay (ELISA), competitive-inhibition ELISA, and immunoblotting. MAb 1B12 bound to live bacterial cells and culture supernatants from a total of 34 strains of M. catarrhalis, including 12 strains with different LPS serotypes. No cross-reactions with smooth and rough LPSs from selected enterobacterial and nonenterobacterial strains, with other respiratory pathogens, or with Neisseria species were observed. These data suggest that MAb 1B12 recognizes a common epitope of M. catarrhalis LPS which differs from serotype determinants.

Full Text

The Full Text of this article is available as a PDF (222.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron J., Shapiro E. D. Unsuspected bacteremia caused by Branhamella catarrhalis. Pediatr Infect Dis. 1985 Jan-Feb;4(1):100–101. doi: 10.1097/00006454-198501000-00025. [DOI] [PubMed] [Google Scholar]
  2. Black A. J., Wilson T. S. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J Clin Pathol. 1988 Mar;41(3):329–333. doi: 10.1136/jcp.41.3.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campagnari A. A., Spinola S. M., Lesse A. J., Kwaik Y. A., Mandrell R. E., Apicella M. A. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens. Microb Pathog. 1990 May;8(5):353–362. doi: 10.1016/0882-4010(90)90094-7. [DOI] [PubMed] [Google Scholar]
  4. Chapman A. J., Jr, Musher D. M., Jonsson S., Clarridge J. E., Wallace R. J., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. doi: 10.1093/infdis/151.5.878. [DOI] [PubMed] [Google Scholar]
  5. Douer D., Danziger Y., Pinkhas J. Neisseria catarrhalis endocarditis. Ann Intern Med. 1977 Jan;86(1):116–116. doi: 10.7326/0003-4819-86-1-116_1. [DOI] [PubMed] [Google Scholar]
  6. Edebrink P., Jansson P. E., Rahman M. M., Widmalm G., Holme T., Rahman M. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr Res. 1995 Jan 17;266(2):237–261. doi: 10.1016/0008-6215(94)00276-l. [DOI] [PubMed] [Google Scholar]
  7. Edebrink P., Jansson P. E., Rahman M. M., Widmalm G., Holme T., Rahman M., Weintraub A. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res. 1994 May 5;257(2):269–284. doi: 10.1016/0008-6215(94)80040-5. [DOI] [PubMed] [Google Scholar]
  8. Faden H., Hong J., Murphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun. 1992 Sep;60(9):3824–3829. doi: 10.1128/iai.60.9.3824-3829.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flesher A. R., Insel R. A. Characterization of lipopolysaccharide of Haemophilus influenzae. J Infect Dis. 1978 Dec;138(6):719–730. doi: 10.1093/infdis/138.6.719. [DOI] [PubMed] [Google Scholar]
  10. Fomsgaard J. S., Fomsgaard A., Høiby N., Bruun B., Galanos C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun. 1991 Sep;59(9):3346–3349. doi: 10.1128/iai.59.9.3346-3349.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galanos C., Lüderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 Jun;9(2):245–249. doi: 10.1111/j.1432-1033.1969.tb00601.x. [DOI] [PubMed] [Google Scholar]
  12. Johnson K. G., McDonald I. J., Perry M. B. Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis. Can J Microbiol. 1976 Apr;22(4):460–467. doi: 10.1139/m76-072. [DOI] [PubMed] [Google Scholar]
  13. Johnson K. G., Perry M. B. Improved techniques for the preparation of bacterial lipopolysaccharides. Can J Microbiol. 1976 Jan;22(1):29–34. doi: 10.1139/m76-004. [DOI] [PubMed] [Google Scholar]
  14. Jönsson I., Holme T., Krook A., Rahman M., Thorén M. Variability of surface-exposed antigens of different strains of Moraxella catarrhalis. Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):919–922. doi: 10.1007/BF01962374. [DOI] [PubMed] [Google Scholar]
  15. Jönsson I., Holme T., Krook A., Thorén M. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria. Eur J Clin Microbiol Infect Dis. 1993 Apr;12(4):289–293. doi: 10.1007/BF01967261. [DOI] [PubMed] [Google Scholar]
  16. Kovatch A. L., Wald E. R., Michaels R. H. beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr. 1983 Feb;102(2):261–264. doi: 10.1016/s0022-3476(83)80537-x. [DOI] [PubMed] [Google Scholar]
  17. Leinonen M., Luotonen J., Herva E., Valkonen K., Mäkelä P. H. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis. 1981 Dec;144(6):570–574. doi: 10.1093/infdis/144.6.570. [DOI] [PubMed] [Google Scholar]
  18. Marchant C. D. Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. Am J Med. 1990 May 14;88(5A):15S–19S. doi: 10.1016/0002-9343(90)90255-c. [DOI] [PubMed] [Google Scholar]
  19. Masoud H., Perry M. B., Richards J. C. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur J Biochem. 1994 Feb 15;220(1):209–216. doi: 10.1111/j.1432-1033.1994.tb18616.x. [DOI] [PubMed] [Google Scholar]
  20. Murphy T. F. The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S75–S77. [PubMed] [Google Scholar]
  21. Nagatake T. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains. Tohoku J Exp Med. 1985 Sep;147(1):1–13. doi: 10.1620/tjem.147.1. [DOI] [PubMed] [Google Scholar]
  22. Oishi K., Koles N. L., Guelde G., Pollack M. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J Infect Dis. 1992 Jan;165(1):34–45. doi: 10.1093/infdis/165.1.34. [DOI] [PubMed] [Google Scholar]
  23. Pollack M., Chia J. K., Koles N. L., Miller M., Guelde G. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989 Feb;159(2):168–188. doi: 10.1093/infdis/159.2.168. [DOI] [PubMed] [Google Scholar]
  24. Sarubbi F. A., Myers J. W., Williams J. J., Shell C. G. Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features. Am J Med. 1990 May 14;88(5A):9S–14S. doi: 10.1016/0002-9343(90)90254-b. [DOI] [PubMed] [Google Scholar]
  25. Schneider H., Hale T. L., Zollinger W. D., Seid R. C., Jr, Hammack C. A., Griffiss J. M. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun. 1984 Sep;45(3):544–549. doi: 10.1128/iai.45.3.544-549.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Smith G. L. Branhamella catarrhalis infection imitating gonorrhea in a man. N Engl J Med. 1987 May 14;316(20):1277–1277. [PubMed] [Google Scholar]
  27. Sonoda F., Oishi K., Tanaka H., Hideaki M., Kobayashi S., Nagatake T., Matsumoto K. [Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract]. Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Jun;29(6):703–709. [PubMed] [Google Scholar]
  28. Tanaka H., Oishi K., Sonoda F., Iwagaki A., Nagatake T., Matsumoto K. [Biochemical analysis of lipopolysaccharides from respiratory pathogenic Branhamella catarrhalis strains and the role of anti-LPS antibodies in Branhamella respiratory infections]. Kansenshogaku Zasshi. 1992 Jun;66(6):709–715. doi: 10.11150/kansenshogakuzasshi1970.66.709. [DOI] [PubMed] [Google Scholar]
  29. Vaneechoutte M., Verschraegen G., Claeys G., Van Den Abeele A. M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol. 1990 Feb;28(2):182–187. doi: 10.1128/jcm.28.2.182-187.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Vaneechoutte M., Verschraegen G., Claeys G., Weise B., Van den Abeele A. M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol. 1990 Dec;28(12):2674–2680. doi: 10.1128/jcm.28.12.2674-2680.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES